Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (18)

2026

  1. Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort

    Seminars in Arthritis and Rheumatism, Vol. 77

2025

  1. Adaptation and validation of the adolescent sleep hygiene scale for Spanish-speaking populations

    Sleep Medicine, Vol. 134

  2. Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus

    Journal of Translational Autoimmunity, Vol. 11

  3. Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project

    Clinical Microbiology and Infection, Vol. 31, Núm. 5, pp. 839-846

  4. Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1

    Annals of the Rheumatic Diseases, Vol. 84, Núm. 7, pp. 1164-1179

  5. Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies

    Journal of Clinical Medicine, Vol. 14, Núm. 5

2024

  1. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

    Reumatologia Clinica, Vol. 18, Núm. 10, pp. 567-573

  3. Hospitalization and Mortality from COVID-19 of Patients with Rheumatic Inflammatory Diseases in Andalusia

    Reumatologia Clinica, Vol. 18, Núm. 7, pp. 422-428

2021

  1. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

  2. Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice

    Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558

2020

  1. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

    Scientific Reports, Vol. 10, Núm. 1

2016

  1. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 11, pp. 1998-2006

2015

  1. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the spanish rheumatology society lupus registry (RELESSER) with emphasis on complete versus incomplete lupus differences

    Medicine (United States), Vol. 94, Núm. 1, pp. e267

  2. PXK locus in systemic lupus erythematosus: Fine mapping and functional analysis reveals novel susceptibility gene ABHD6

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 3

2014

  1. Standards of care for patients with spondyloarthritis

    Rheumatology International, Vol. 34, Núm. 2, pp. 165-170

2010

  1. Power doppler ultrasonography assessment of entheses in spondyloarthropathies: Response to therapy of entheseal abnormalities

    Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2110-2117